Because abnormal expression of mmp9 and mmp13 occurs in human diseases such as cancer, arthritis and cardiovascular disorders, small molecule inhibitors specific to MMP9 and MMP13, respectively, or to both MMP9 and MMP13 were available [11,12]. This evidence concerns the gene MMP9 and cardiovascular disorder.